MétaCan
Menu
Back to cohort
Record W2080731610 · doi:10.1016/j.crvasa.2014.01.006

Use of ezetimibe results in more patients reaching lipid targets without side effects

2014· article· en· W2080731610 on OpenAlexaff
Michal Vrablı́k, Daniel T. Holmes, Barry Forer, Andrew J. Juren, Pawel Martinka, Jiří Fröhlich

Bibliographic record

VenueCor et Vasa · 2014
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsSt. Paul's HospitalUniversity of British Columbia
Fundersnot available
KeywordsEzetimibeInternal medicinePhysicsCholesterolMedicineEndocrinology

Abstract

fetched live from OpenAlex

Úvod: Mechanismus účinku ezetimibu doplňuje účinek statinĹŻ, a tudĂ­Ĺž je ezetimib vhodnou léčbou pro pacienty, kteří netolerujĂ­ hypolipidemika, nebo pro ty, kteří nedosahujĂ­ cĂ­lovĂ˝ch hodnot lipidĹŻ.CĂ­l: Zhodnotit účinnost a bezpečnost ezetimibu při dlouhodobĂŠm sledovĂĄnĂ­ pacientĹŻ v lipidologickĂŠ ambulanci s dĹŻrazem na motivaci k léčbě a vliv na dosaĹženĂ­ cĂ­lovĂ˝ch hodnot lipidĹŻ.Metody: V naĹĄĂ­ databĂĄzi jsme identifikovali 295 ambulantnĂ­ch pacientĹŻ, u kterĂ˝ch byla zahĂĄjena léčba ezetimibem v době 13 měsĂ­cĹŻ po uvedenĂ­ tohoto lĂŠku na kanadskĂ˝ trh. AnamnestickĂĄ a laboratornĂ­ data byla shromažďovĂĄna před zahĂĄjenĂ­m léčby a při prvnĂ­ nĂĄvĹĄtěvě po zahĂĄjenĂ­ léčby. Pro statistickĂŠ srovnĂĄnĂ­ účinku ezetimibu na parametry lipidovĂŠho metabolismu byl pouĹžit pĂĄrovĂ˝ t-test a pro hodnocenĂ­ účinku na dosaĹženĂ­ cĂ­lovĂ˝ch hodnot lipidĹŻ byl pouĹžit χ2 test.VĂ˝sledky: Léčba ezetimibem vedla ke zvýťenĂ­ podĂ­lu pacientĹŻ, kteří dosĂĄhli cĂ­lovĂŠ hodnoty lipidĹŻ (o 25 % pro LDL cholesterol a o 21,7 % pro poměr celkovĂŠho/HDL cholesterolu; p ≤ 0,001). Monoterapie ezetimibem vedla k vĂ˝znamnĂŠmu snĂ­ĹženĂ­ LDL cholesterolu o 18 % (p < 0,001) a poměru celkovĂŠho/HDL cholesterolu o 15 % (p < 0,011). Účinek ezetimibu kombinovanĂŠho s jinĂ˝mi hypolipidemiky byl obdobnĂ˝; LDL cholesterol se snĂ­Ĺžil o 22 % (p < 0,001) a poměr celkovĂŠho/HDL cholesterolu o 15,4 % (p < 0,011). StejnĂ˝ hypolipidemickĂ˝ účinek byl zjiĹĄtěn u diabetikĹŻ. V tĂŠto podskupině nemocnĂ˝ch vedlo přidĂĄnĂ­ ezetimibu k dosavadnĂ­ léčbě k trojnĂĄsobnĂŠmu nĂĄrĹŻstu pacientĹŻ, kteří dosĂĄhli cĂ­lovĂ˝ch hodnot LDL cholesterolu, a dvojnĂĄsobnĂŠmu nĂĄrĹŻstu počtu pacientĹŻ, kteří dosĂĄhli cĂ­lovĂŠho poměru celkovĂŠho/HDL cholesterolu. Pouze 7 % pacientĹŻ přeruĹĄilo léčbu pro neŞådoucĂ­ účinky.ZĂĄvěr: U pacientĹŻ, kteří byli odeslĂĄni do specializovanĂŠho lipidologickĂŠho centra (typicky pro neŞådoucĂ­ účinky hypolipidemik nebo nemoĹžnost dosĂĄhnout cĂ­lovĂ˝ch hodnot), vedla léčba ezetimibem k vĂ˝znamnĂŠmu nĂĄrĹŻstu podĂ­lu těch, kteří dosĂĄhli cĂ­lovĂ˝ch hodnot lipidĹŻ. Tato léčba nebyla provĂĄzena vĂ˝znamnĂ˝mi neŞådoucĂ­mi účinky.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.050

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0150.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.276
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueCor et VasaSame topicLipoproteins and Cardiovascular HealthFrench-language works237,207